In the US, Cancidas (caspofungin systemic) is a member of the drug class echinocandins and is used to treat Aspergillosis - Invasive, Candida Infections - Systemic, Esophageal Candidiasis and Febrile Neutropenia.
US matches:
- Cancidas
UK matches:
- CANCIDAS 50 mg (formerly Caspofungin MSD)
- CANCIDAS 70 mg (formerly Caspofungin MSD)
- CANCIDAS (formerly Caspofungin MSD) (SPC)
Ingredient matches for Cancidas
Caspofungin is reported as an ingredient of Cancidas in the following countries:
- Spain
- Tunisia
Caspofungin diacetate (a derivative of Caspofungin) is reported as an ingredient of Cancidas in the following countries:
- Algeria
- Argentina
- Aruba
- Australia
- Austria
- Bahamas
- Barbados
- Belgium
- Belize
- Bosnia & Herzegowina
- Brazil
- Canada
- Cayman Islands
- Chile
- China
- Colombia
- Croatia (Hrvatska)
- Czech Republic
- Denmark
- Dominican Republic
- Ecuador
- Finland
- France
- Germany
- Greece
- Hong Kong
- Hungary
- Iceland
- Ireland
- Israel
- Italy
- Jamaica
- Luxembourg
- Malaysia
- Mexico
- Netherlands
- Netherlands Antilles
- New Zealand
- Norway
- Peru
- Philippines
- Romania
- Russian Federation
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- Sweden
- Switzerland
- Taiwan
- Thailand
- Trinidad & Tobago
- Turkey
- United Kingdom
- United States
- Venezuela
International Drug Name Search
Glossary
SPC | Summary of Product Characteristics (UK) |
Click for further information on drug naming conventions and International Nonproprietary Names.